[1] Nejat EJ, Polotsky AJ, Pal I. Predictors of chronic disease at midlife and beyond the health risks of obesity[J]. Maturitas,2010, 65(2):106-111. [2] Adams KF, Schatzkin A, Harris TB,et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old [J].N Engl J Med,2006, 355(8):763-778. [3] Pocock SJ, McMurray JJ, Dobson j,et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme [J].Eur Heart J,2008, 29 (21):2641-2650. [4] Lavie CJ, Milani RV, Artham SM, et al. The obesity paradox, weight loss, and coronary disease [J].Am J Med,2009, 122(12): 1106-1114. [5] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011, 39(7): 579-616. [6] 陈春明,孔灵芝.中国成人超重和肥胖症预防与控制指南(试行)[M].北京:人民卫生出版社,2006. [7] Fonarow GC, Srikanthan P, Costanzo MR, et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108, 927patients in the Acute Decompensated Heart Failure National Registry [J].Am Heart J,2007, 153(1): 74-81. [8] Clark AL, Chyu J, Horwich TB. The obesity paradox in men versus women with systolic heart failure [J].Am J Cardiol,2012, 110(1): 77-82. [9] Angeras O, Albertsson P, Karason K, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry [J].Eur Heart J,2013, 34(5): 345-353. [10] Henkeveld L, Magro M, Oemrawsingh RM, et al. The influence of optimal medical treatment on the 'obesity paradox', body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study [J].BMJ Open,2012, 2: e000535. [11] Alpert MA, Omran j, Mehra A, et al.Impact of obesity and weight loss on cardiac performance and morphology in adults [J].Prog Cardiovasc Dis,2014, 56(4): 391-400. [12] 田歌,陶贵周,屈宝泽,等. 肥胖矛盾现象及其对治疗的启示[J].医学与哲学, 2012, 33(1): 32-33.
2018, Vol. 35 
